Raffles Medical Group Inkomsten in het verleden
Verleden criteriumcontroles 2/6
Raffles Medical Group is de winst gegroeid met een gemiddeld jaarlijks percentage van 12.9%, terwijl de Healthcare industrie de winst jaarlijks groeide met 5.8%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 9.1% per jaar. Het rendement op eigen vermogen van Raffles Medical Group is 6%, en het heeft een nettomarge van 8.7%.
Belangrijke informatie
12.9%
Groei van de winst
12.4%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 9.7% |
| Inkomstengroei | 9.1% |
| Rendement op eigen vermogen | 6.0% |
| Nettomarge | 8.7% |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Raffles Medical Group (SGX:BSL) Is Reducing Its Dividend To SGD0.024
May 09
Raffles Medical Group's (SGX:BSL) Dividend Is Being Reduced To SGD0.024
Apr 25Raffles Medical Group's (SGX:BSL) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Apr 10Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)
Nov 16Raffles Medical Group (SGX:BSL) Is Doing The Right Things To Multiply Its Share Price
Nov 03Here's Why Raffles Medical Group (SGX:BSL) Has Caught The Eye Of Investors
Aug 23The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising
Jul 24Raffles Medical Group (SGX:BSL) Could Easily Take On More Debt
Jun 13A Look At The Fair Value Of Raffles Medical Group Ltd (SGX:BSL)
May 30Is Now The Time To Put Raffles Medical Group (SGX:BSL) On Your Watchlist?
May 12Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To SGD0.038
May 01Raffles Medical Group (SGX:BSL) Might Have The Makings Of A Multi-Bagger
Mar 13Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)
Feb 14Returns At Raffles Medical Group (SGX:BSL) Are On The Way Up
Dec 04Do Raffles Medical Group's (SGX:BSL) Earnings Warrant Your Attention?
Nov 21Is There An Opportunity With Raffles Medical Group Ltd's (SGX:BSL) 25% Undervaluation?
Oct 09Is Raffles Medical Group (SGX:BSL) A Risky Investment?
Sep 26The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising
Sep 01With EPS Growth And More, Raffles Medical Group (SGX:BSL) Makes An Interesting Case
Aug 20Raffles Medical Group (SGX:BSL) Has Some Way To Go To Become A Multi-Bagger
Jun 01Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To S$0.028
May 02We Think Raffles Medical Group (SGX:BSL) Can Manage Its Debt With Ease
Apr 18Slowing Rates Of Return At Raffles Medical Group (SGX:BSL) Leave Little Room For Excitement
Feb 21Raffles Medical Group (SGX:BSL) Seems To Use Debt Rather Sparingly
Oct 14Raffles Medical Group (SGX:BSL) Has Some Way To Go To Become A Multi-Bagger
Oct 02At S$1.40, Is Raffles Medical Group Ltd (SGX:BSL) Worth Looking At Closely?
Sep 21Here's Why I Think Raffles Medical Group (SGX:BSL) Is An Interesting Stock
Aug 12Here's What's Concerning About Raffles Medical Group's (SGX:BSL) Returns On Capital
Jul 01At S$1.08, Is It Time To Put Raffles Medical Group Ltd (SGX:BSL) On Your Watch List?
May 25Does This Valuation Of Raffles Medical Group Ltd (SGX:BSL) Imply Investors Are Overpaying?
Apr 05Opbrengsten en kosten
Hoe Raffles Medical Group geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 703 | 61 | 163 | 0 |
| 31 Mar 24 | 706 | 76 | 153 | 0 |
| 31 Dec 23 | 708 | 90 | 142 | 0 |
| 30 Sep 23 | 747 | 117 | 184 | 0 |
| 30 Jun 23 | 786 | 144 | 165 | 0 |
| 31 Mar 23 | 805 | 143 | 137 | 0 |
| 31 Dec 22 | 825 | 143 | 110 | 0 |
| 30 Sep 22 | 808 | 124 | 62 | 0 |
| 30 Jun 22 | 791 | 104 | 13 | 0 |
| 31 Mar 22 | 758 | 94 | 10 | 0 |
| 31 Dec 21 | 725 | 84 | 7 | 0 |
| 30 Sep 21 | 698 | 86 | 7 | 0 |
| 30 Jun 21 | 671 | 88 | 7 | 0 |
| 31 Mar 21 | 619 | 77 | 7 | 0 |
| 31 Dec 20 | 568 | 66 | 7 | 0 |
| 30 Sep 20 | 541 | 60 | 9 | 0 |
| 30 Jun 20 | 508 | 50 | 8 | 0 |
| 31 Mar 20 | 514 | 55 | 9 | 0 |
| 31 Dec 19 | 522 | 60 | 10 | 0 |
| 30 Sep 19 | 514 | 63 | 14 | 0 |
| 30 Jun 19 | 504 | 66 | 16 | 0 |
| 31 Mar 19 | 497 | 69 | 15 | 0 |
| 31 Dec 18 | 489 | 71 | 20 | 0 |
| 30 Sep 18 | 484 | 71 | 18 | 0 |
| 30 Jun 18 | 483 | 71 | 17 | 0 |
| 31 Mar 18 | 483 | 71 | 16 | 0 |
| 31 Dec 17 | 478 | 71 | 15 | 0 |
| 30 Sep 17 | 473 | 70 | 16 | 0 |
| 30 Jun 17 | 473 | 70 | 16 | 0 |
| 31 Mar 17 | 472 | 70 | 16 | 0 |
| 31 Dec 16 | 474 | 70 | 16 | 0 |
| 30 Sep 16 | 470 | 71 | 16 | 0 |
| 30 Jun 16 | 452 | 71 | 15 | 0 |
| 31 Mar 16 | 432 | 70 | 14 | 0 |
| 31 Dec 15 | 411 | 69 | 13 | 0 |
| 30 Sep 15 | 396 | 69 | 11 | 0 |
| 30 Jun 15 | 389 | 68 | 11 | 0 |
| 31 Mar 15 | 382 | 68 | 10 | 0 |
| 31 Dec 14 | 375 | 68 | 10 | 0 |
| 30 Sep 14 | 363 | 89 | 9 | 0 |
| 30 Jun 14 | 353 | 87 | 9 | 0 |
| 31 Mar 14 | 347 | 86 | 9 | 0 |
| 31 Dec 13 | 341 | 85 | 9 | 0 |
Kwaliteitswinsten: BSL heeft hoge kwaliteitsinkomsten.
Groeiende winstmarge: De huidige netto winstmarges (8.7%) BSL } zijn lager dan vorig jaar (18.3%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: De winst van BSL is de afgelopen 5 jaar met 12.9% per jaar gegroeid.
Versnelling van de groei: De winstgroei BSL is het afgelopen jaar negatief geweest en kan daarom niet worden vergeleken met het 5-jarig gemiddelde.
Winst versus industrie: BSL had het afgelopen jaar een negatieve winstgroei ( -57.5% ), waardoor het moeilijk is om te vergelijken met het branchegemiddelde Healthcare ( -26% ).
Rendement op eigen vermogen
Hoge ROE: Het Rendement op eigen vermogen ( 6% ) van BSL wordt als laag beschouwd.